Liraglutide Reduces Visceral Fat in Overweight, Obese Adults
WEDNESDAY, Aug. 25, 2021 -- For overweight and obese adults at high cardiovascular risk, liraglutide reduces visceral adipose tissue, according to a study published online Aug. 3 in The Lancet Diabetes& Endocrinology.
Ian J. Neeland, M.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Obesity | Pharmaceuticals | Study | Victoza